Sun Pharmaceuticals received permission to market Wellbutrin
Submitted by Piyush Diwan on Fri, 04/09/2010 - 01:41.
United States Food and Drug Administration (FAD) had contracted India's Sun Pharmaceuticals Limited to market generic version of GlaxoSmithKline's Wellbutrin SR Extended Release tablets.
Company in a press release expressed that Wellbutrin is used for treating serious depressive disorders.
Company also told that Wellbutrin will be alike the generic Bupropion Hydrochoride Extended Release tablets. These are available in 3 strengths: 100mg, 150mg and 200mg.
All these tablets with different strengths jointly account for annual sale of approximately $ 300 million in the US.
.
Technical View on Stocks
Recent Images
Technology Sector
Buzzing Stocks
Energy Sector
Check out More news from Telecom Sector :: Pharmaceutical Sector :: Auto Sector :: Infrastructure :: Real Estate
